1. Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of the Thrombospondin-1–Mimetic Angiogenesis Inhibitor ABT-510 in Patients With Advanced Cancer
   Ronald Hoekstra et al, 2005, Journal of Clinical Oncology CrossRef